Fluoxetine affects embryonic morphogenesis by inhibiting the activity of the Wnt signaling pathway and reducing cell proliferation, and activation of the Wnt signaling pathway partially mitigates the adverse effects of fluoxetine on embryonic morphology through a mechanism of action that is not directly related to the inhibition of serotonin reuptake in the synapse
However, individual outcomes may vary based on factors such as starting weight and adherence to the program
Microdosing GLP-1s may provide support during this transition by helping regulate appetite, energy, and metabolic stability
It also slows down the digestive process, allowing the stomach to feel full for extended periods of time
[2] As a 503B-compounded medication, it is not an FDA-approved commercially marketed drug
Prioritize Hydration and Electrolytes Because the medication can cause you to lose fluids and sodium, staying hydrated is critical